Adial Pharmaceuticals, Inc. Gain (Loss) on Extinguishment of Debt
Adial Pharmaceuticals, Inc. (ADIL) reported Gain (Loss) on Extinguishment of Debt of -$6.05 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2026-08-14
- Adial Pharmaceuticals, Inc. gain (loss) on extinguishment of debt for the quarter ending 2026-06-30 was -$6.05M.
- Adial Pharmaceuticals, Inc. gain (loss) on extinguishment of debt for the quarter ending 2018-12-31 was $0.00.
- Adial Pharmaceuticals, Inc. gain (loss) on extinguishment of debt for the quarter ending 2018-09-30 was -$3.50M.
- Adial Pharmaceuticals, Inc. gain (loss) on extinguishment of debt for the quarter ending 2018-06-30 was $0.00.
- Adial Pharmaceuticals, Inc. gain (loss) on extinguishment of debt for fiscal 2018 was -$3.48M.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 6 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$6.05M 10-Q · filed 2026-08-14 | -$6.05M 10-Q · filed 2026-08-14 | ||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-20 | -$3.50M derived: sum of 2 quarters · filed 2020-03-20 | -$3.50M derived: sum of 3 quarters · filed 2020-03-20 | -$3.48M 10-K · filed 2020-03-20 |
| 2018-09-30 | -$3.50M 10-Q · filed 2019-11-14 | -$3.50M derived: sum of 2 quarters · filed 2019-11-14 | -$3.48M 10-Q · filed 2019-11-14 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $12.24K 10-Q · filed 2019-08-13 | ||
| 2018-03-31 | $12.24K 10-Q · filed 2019-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |